Stephen Betz
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Stephen F.
Betz is the founder of Crinetics Pharmaceuticals, Inc., founded in 2008, where the title held is Chief Scientific Officer since 2021.
Former jobs include Director-Endocrinology & Metabolism at Neurocrine Biosciences, Inc. from 2003 to 2009, and Head-Laboratory Efforts at GeneFormatics, Inc. from 2001 to 2003.
Education history includes an undergraduate degree from the University of Delaware in 1987 and a doctorate from The University of North Carolina at Chapel Hill in 1993.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 57 451 ( 0,06% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Fondateur | 01/01/2008 |
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Corporate Officer/Principal | 01/01/2003 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national